Durolane 60 MG/3 ML syringe 3ML
Ended Awarded
- Contract number
- SPE2DB25FDL10
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,272
Award facts
- Contract value 100% obligated
- $10,272.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,272 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Durolane 60 mg/3 mL syringes, with an ultimate completion date of September 4, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order falls under the company's existing single-award Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which authorizes the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
Durolane is a hyaluronic acid-based intra-articular injection used primarily for osteoarthritis treatment in joints. As a specialized pharmaceutical product supplier to federal agencies, DMS Pharmaceutical Group has established itself as a critical vendor in the military healthcare supply chain, delivering prescription medications, biologics, medical consumables, and specialty pharmaceutical items to Department of Defense facilities. The company's contract portfolio demonstrates consistent capability in sourcing both branded and generic pharmaceuticals across diverse therapeutic categories, positioning it as a reliable distributor for the medical supply requirements of military health systems nationwide.
Quick answers
Who was awarded contract SPE2DB25FDL10?
SPE2DB25FDL10 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FDL10 worth?
The government has obligated $10,272 on SPE2DB25FDL10.
Is contract SPE2DB25FDL10 an order under another contract?
Yes. SPE2DB25FDL10 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL10 competed?
The extent of competition for SPE2DB25FDL10 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award